News

Article

PTSM: Pharmaceutical Technology Sourcing and Management

PTSM: Pharmaceutical Technology Sourcing and Management

PTSM: Pharmaceutical Technology Sourcing and Management-08-03-2016
Volume11
Issue 8

Saneca Pharma Secures Contract Manufacturing Agreement with Xantis Pharma

CDMO Saneca Pharma has sold registration dossiers for more than 20 pharmaceutical products to Xantis Pharma and will hold an exclusive five-year contract manufacturing agreement for the products with Xantis Pharma.

Saneca Pharma, a contract development and manufacturing organization (CDMO) based in Slovakia, announced that it has sold registration dossiers for more than 20 pharmaceutical products to Swiss company Xantis Pharma as part of an exclusive agreement. The portfolio of products will be marketed by Xantis Pharma throughout Central and Eastern Europe.  

Under the terms of the agreement, the European CDMO will hold an exclusive five-year contract manufacturing agreement for the products with Xantis Pharma. Saneca Pharma will continue to act as Xantis Pharma’s agent for out-licensing opportunities for the dossiers outside of these regions.  

The two firms have also committed to working together to develop nine new products in the next three years. While Saneca Pharma will use its expertise in formulation development and regulatory support, Xantis Pharma will promote the new offerings to the market.

Source: Saneca Pharma

 

 

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
Simona Guidi, Associate Director, ProPharma
Tore Bergsteiner
Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More
Related Content